Buckle up for a bumpy ride! I have no feel for what the stock will do now. Just going on blind faith that science is good and Brilla will prevail. All I can say beyond that is, after seeing Kevetrin in a phase I for two years and on cohort 9 likely going to 10, thank God (and Leo, if they aren't the same) for Brilacidin! Otherwise...I shudder to think where this stock would be.
Go CTIX!
Prediction for the day...wobbly start, low of $2.08, close at $2.19 with +/- 300k volume.